The immunopotentiating drug, levamisole, was found to augment human lymphocyte
responses to vegetable mitogens in vitro. However, the effect was dose-dependent and at …

The immunostimulatory activity of tetramisole and its levo isomer levamisole, has been
investigated in tumorous and non-tumorous experimental animals. These compounds were …

Levamisole, an antihelminthic drug with immunological properties, has recently been
reported to have antitumor activity when administered with 5-fluorouracil in patients with …

The history of the use of levamisole in man is summarized, from its start as an anthelmintic in
the early sixties, through its world-wide recognition as an immunotropic agent especially in …

The effects of levamisole were studied by evaluating T-cell responsiveness to a low dose of
PHA on 31 advanced cancer volunteers. Treatment consisted in a 3-time a week oral …

This account of levamisole refers to its pharmacokinetics and its anthelmintic and
immunomodulating activities, including the mechanisms of such activities. Levamisole is …

Levamisole, an agent acting upon depressed cellular immunity, enhancing and normalizing
it and consequently showing antitumor activity in the cancer-bearing body, was administered …

Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …

The immunopotentiating drug, levamisole, was found to augment human lymphocyte
responses to allogeneic cells and plant mitogens in vitro. The effect was critically dose …